Recovery timelines
Our post-ibogaine timeline organizes common questions by phase, without treating recovery as a fixed schedule or a promise of a particular outcome.
Independent information services
Open Field 31 offers careful, plain-language ways to orient around life after ibogaine: what recovery can look like, what uncertainty remains, and how questions about safety, integration, follow-up, and relapse prevention can be approached over time.
A grounded starting point
The material here is not treatment. It is a set of guides, comparisons, definitions, research summaries, and questions intended to help people and loved ones find a steadier frame for decisions after an ibogaine experience.
Our post-ibogaine timeline organizes common questions by phase, without treating recovery as a fixed schedule or a promise of a particular outcome.
We map practical considerations around routines, support, changing needs, and uncertainty through the integration and relapse support guide, while recognizing that relapse prevention is not a single event or method.
Our risk and monitoring guide helps separate questions that may need prompt professional attention from the wider work of making sense of recovery.
For the purpose, scope, and limits of this independent resource, see how Open Field 31 approaches its information. It is designed for people considering or navigating life after ibogaine, and for loved ones seeking grounded context.
Comparisons & research summaries
Ibogaine is commonly discussed in relation to substance use and recovery, but the evidence base and the surrounding practical decisions need careful reading. A basic description of ibogaine can be useful for orientation, while safety questions should not be reduced to broad claims online.
We compare terms, settings, and decision points people may encounter: from the different names used for ibogaine to questions about treatment-center options in the United States and affordability considerations around treatment. These are informational comparisons, not endorsements or referrals.
A human measure
“A meaningful experience can still leave practical questions. Time, support, and honest monitoring can matter after the intensity has passed.”
FAQ collection
Open Field 31 does not replace medical or legal guidance. When concerns involve immediate safety, symptoms, medication changes, or relapse risk, context from qualified local professionals is important.
Follow-up can mean different things in different circumstances: reflecting on sleep, mood, routines, support, and any concerns that need clinical attention. Our material on spiritual reset narratives examines one kind of language people may encounter, while keeping space for individual uncertainty and practical needs.
Ibogaine has been associated with serious cardiac concerns, which is why risk information should be handled cautiously. The FDA’s drug-safety information provides a broader public-health context for why medication and substance safety questions warrant careful attention.
Comparison pages can help identify questions, not make decisions for someone. We cover ibogaine clinic questions in Tijuana and treatment-cost considerations in Mexico as areas where claims, finances, travel, follow-up, and safety should be examined separately.
It can affect access, decision-making, and what information people encounter. Our explanation of whether ibogaine is illegal in the United States is intended as general context rather than legal advice. For longer-term questions about the body and recovery narratives, our overview of ibogaine and neuroregeneration claims emphasizes the difference between possibility, evidence, and certainty.
Keep the frame practical
Return to the life-after-ibogaine overview for a calm, plain-language starting point on support, safety awareness, follow-up, uncertainty, and relapse-prevention considerations.